JUVE Patent

df-mp – UPC 2026

JUVE Comment

This pure patent attorney firm has established itself as a significant player in UPC litigation. Regular clients, including InterDigital, now routinely pursue their campaigns at the UPC, relying on df-mp’s patent attorneys as extensively as they do in national proceedings. The tech team’s workload is now evenly split between UPC and national cases, largely because long-standing clients have broadened their litigation strategies to encompass the UPC. The patent attorneys work seamlessly alongside lawyers, leveraging relationships cultivated over many years of national proceedings.

This collaborative approach extends to the life sciences experts. Elisabeth Greiner played a pivotal role for client Zentiva in one of the UPC’s first major proceedings between generics manufacturers and originators concerning cabazitaxel. This landmark case demonstrates the life sciences team’s potential at the UPC, particularly as pharmaceutical clients increasingly bring proceedings before the court and face litigation there themselves.

Strengths

Litigation for clients in mobile communications and life sciences.

Recommended individuals

Elisabeth Greiner (“extremely efficient, creative and focused, pleads in a way that a judge understands the complex issues, clear and concise arguments, highly experienced in Germany, EPO and UPC, knows how to get the best result”, competitor), Dominik Ho (“finds a solution even for insoluble cases”, competitor)

Team

34 patent attorneys, 1 lawyer, 2 dual qualified

Partner move

Ju Min Kim (from Vossius & Brinkhof UPC Litigators)

Clients

Zentiva against Sanofi over use of cabazitaxel to treat tumours; InterDigital against Disney over video streaming technology; InterDigital against Transsion over coding; ParTec against NVIDIA over microprocessors; Nokia against Sunmi over mobile communications; Huawei against MediaTek over 4G and 5G; AX Wireless against Xiomi over wi-fi; Malikie against Xiomi over mobile communications.

Location

Munich